Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions

Details for Australian Patent Application No. 2006309008 (hide)

Owner Lpath, Inc.

Inventors Sabbadini, Roger A.; Garland, William A.; Stoller, Glenn L.

Agent Spruson & Ferguson

Pub. Number AU-A-2006309008

PCT Pub. Number WO2007/053447

Priority 11/261,935 28.10.05 US

Filing date 27 October 2006

Wipo publication date 10 May 2007

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/053447 Priority application(s): WO2007/053447

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006309013-Bi-aryl meta-pyrimidine inhibitors of kinases

2006309007-Use of vaccines for the treatment/ prevention of the transmission of influenza pathogens between species